Factors affecting the development of liver fibrosis in patients who experienced COVID-19

QR Code

Factors affecting the development of liver fibrosis in patients who experienced COVID-19

The aim of the review is to highlight the main factors affecting the development of liver fibrosis and possible mechanisms of liver damage in patients who have experienced COVID-19. A search was carried out using keywords in the Scopus, Web of Science, and PubMed databases in literary sources of the...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Kruchinina, N. E. Pershina, I. O. Svetlova, E. V. Kruchinina
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2023-07-01
Series:	Бюллетень сибирской медицины
Subjects:	factors liver fibrosis covid-19
Online Access:	https://bulletin.ssmu.ru/jour/article/view/5230
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Management of Pulmonary Fibrosis in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2021-07-01)

Fibrosis of the cardiovascular and respiratory systems after suffering COVID-19: the contribution of immune system factors and genetic predisposition
by: A. S. Golovkin, et al.
Published: (2020-11-01)

Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment
by: Cleopas Martin Rumende
Published: (2021-07-01)

Modern concepts on pathogenetic mechanisms of liver fibrosis
by: N. A. Efremova, et al.
Published: (2023-04-01)

Non-alcoholic fatty liver disease and metabolic liver dysfunction in the new coronavirus infection COVID-19
by: A. A. Karaseva, et al.
Published: (2021-12-01)

Quantitative ultrasound rating of liver fibrosis in children with cystic fibrosis
by: G. M. Dvoryakovskaya, et al.
Published: (2014-08-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Current strategies for targeted therapy of liver fibrosis
by: D. V. Garbuzenko
Published: (2022-10-01)

A METHOD OF INTEGRATED ASSESSMENT OF LIVER FIBROSIS DEGREE: A COMPARISON OF THE OPTICAL METHOD FOR THE STUDY OF RED BLOOD CELLS AND INDIRECT ELASTOGRAPHY OF THE LIVER
by: M. V. Kruchinina, et al.
Published: (2017-04-01)

Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2015-05-01)

COVID-19 and liver dysfunction: current ideas and new therapeutic strategies
by: E. A. Lyalyukova, et al.
Published: (2021-06-01)

Gene therapy by hepatocyte growth factor results in regression of experimental liver fibrosis
by: N. A. Dzhoyashvili, et al.
Published: (2010-08-01)

Prolonged course of novel coronavirus infection COVID-19 with the formation of pulmonary fibrosis in an HIV-infected patient
by: M. A. Savchenko, et al.
Published: (2024-04-01)

The Course of Alcoholic Cirrhosis of The Liver in a Patient with COVID-19
by: E. Y. Kudashkina, et al.
Published: (2022-05-01)

Chronic Liver Diseases and COVID-19: Database of General Hospital
by: E. Yu. Sitnikova, et al.
Published: (2023-01-01)

The Adverse consequence of covid-19 causing liver and kidney dysfunctions
by: Omar Falah Ibrahim
Published: (2022-12-01)

The use of bicyclol in the treatment of severe liver fibrosis: experimental rationale
by: K. V. Zhdanov, et al.
Published: (2021-01-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

The effect of fucoxanthin on the development of CCl<sub>4</sub>-induced liver fibrosis
by: V. N. Slautin, et al.
Published: (2023-06-01)

Clinical course and outcomes of COVID-19 infection in liver transplant recipients: single-center cross-sectional study
by: S. E. Voskanyan, et al.
Published: (2022-03-01)

Defenestration of Liver Sinusoidal Endothelial Cells: The Trigger of Liver Fibrosis
by: Juntao Zhou, et al.
Published: (2025-06-01)

EFFECT OF COVID-19 ON GASTROINTESTINAL TRACT AND LIVER, MANIFESTATIONS, PROGNOSIS, MECHANISMS, TREATMENT, AND CHALLENGES: A COMPREHENSIVE REVIEW
by: Subhan Haider, et al.
Published: (2023-09-01)

Features of lung impairment due to COVID-19 in patients of the first wave of the pandemic (literature review)
by: Yu.I. Feshchenko, et al.
Published: (2022-12-01)

Current Update on DWI-MRI and Its Radiomics in Liver Fibrosis—A Review of the Literature
by: Ali S. Alyami
Published: (2025-05-01)

Features of cellular immunity and regeneration for alcoholic fibrosis of the liver
by: N. D. Gazatova, et al.
Published: (2019-05-01)

Analysis of expression profile of long non-coding RNA in patients with idiopathic and COVID-19-induced pulmonary fibrosis
by: G. F. Korytina, et al.
Published: (2023-12-01)

Shear Wave Elastography and Shear Wave Dispersion for Assessing Fibrosis and Inflammation of Liver Tissue in Children with Juvenile Autoimmune Liver Diseases
by: Maryna Dyba, et al.
Published: (2025-04-01)

Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis
by: O. K. Batsunov, et al.
Published: (2020-04-01)

A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
by: A. A. Ostanin, et al.
Published: (2014-07-01)

EXTRACELLULAR MATRIX CONDITION IN CASE OF HCVASSOCIATED LIVER FIBROSIS
by: I. S. Gorelova, et al.
Published: (2017-01-01)

Comparison of Transient Elastography and Liver Biopsy in Assessing Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Gaurav Bachhav, et al.
Published: (2021-05-01)

Adiponectin level and severity of liver fibrosis in patients chronic hepatitis C with metabolic syndrome
by: A. F. Novikova, et al.
Published: (2018-07-01)

Improved Translational Relevance of In Vitro Fibrosis Models by Integrating IOX2-Mediated Hypoxia-Mimicking Pathways
by: Manuel A. González Hernández, et al.
Published: (2025-06-01)

Treatment of varicothrombophlebitis in patients who have been new coronavirus infection COVID-19
by: E. P. Krivoshchekov, et al.
Published: (2022-05-01)

Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis
by: Qiao Guanen, et al.
Published: (2025-07-01)

Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway
by: Johnny Amer, et al.
Published: (2025-06-01)

COVID-19 severity prediction in patients with chronic hepatitis C depending on the liver fibrosis stage
by: E. N. Temnik, et al.
Published: (2024-06-01)

Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection
by: Sharmila Fagoonee, et al.
Published: (2025-07-01)

First living donor liver transplantation for congenital hepatic fi brosis in Azerbaijan
by: R. A. Mamedov, et al.
Published: (2017-06-01)

The impact of biological and psychosocial factors on the formation of mental disorders in patients who have experienced COVID-19 and exposed to the stressors of the SARS-COV-2 pandemic
by: N.O. Maruta, et al.
Published: (2023-12-01)